Cryo Cell International (CCEL) Research & Development (2010 - 2026)
Cryo Cell International (CCEL) posted quarterly Research & Development of $99781.0 for Q2 2026, down 24.24% year-over-year from $131711.0 in Q2 2025, and up 51.73% quarter-over-quarter from $65761.0 in Q1 2026.
Powered by 
Analysis
Cryo Cell International (CCEL) Research & Development (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Research & Development for 17 consecutive years, with $99781.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development fell 24.24% year-over-year to $99781.0; the TTM figure through May 2026 stood at $311951.0 (down 57.17% YoY), while the FY2025 annual figure was $376263.0, down 69.72% from the prior year.
- Research & Development grew to $99781.0 in Q2 2026 per CCEL's latest filing, from $65761.0 in the prior quarter.
- Across five years, Research & Development topped out at $502889.0 in Q1 2024 and bottomed at $61625.0 in Q3 2025.
- Historically, Research & Development has averaged $185588.1 across 5 years, with a median of $115746.0 in 2025.
- Annual changes were most pronounced in 2022 — Research & Development jumped 2399.1% — and 2025, when it slumped 80.48%.
- Cryo Cell International's Research & Development stood at $76401.0 in 2022, then soared by 480.89% to $443808.0 in 2023, then sank by 31.36% to $304629.0 in 2024, then tumbled by 72.17% to $84784.0 in 2025, then rose by 17.69% to $99781.0 in 2026.
- Business Quant data shows CCEL's Research & Development at $99781.0 in Q2 2026, $65761.0 in Q1 2026, and $84784.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | - |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | - |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | - |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | - |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | - |
| 10 | Cryo Cell International | 32.55 Mn | 29.39 Mn | 6.10 Mn | 99,781.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 99,781.00 |
| Feb 28, 2026 | 65,761.00 |
| Nov 30, 2025 | 84,784.00 |
| Aug 31, 2025 | 61,625.00 |
| May 31, 2025 | 131,711.00 |
| Feb 28, 2025 | 98,143.00 |
| Nov 30, 2024 | 304,629.00 |
| Aug 31, 2024 | 193,933.00 |
| May 31, 2024 | 241,085.00 |
| Feb 29, 2024 | 502,889.00 |
| Nov 30, 2023 | 443,808.00 |
| Aug 31, 2023 | 344,132.00 |
| May 31, 2023 | 304,682.00 |
| Feb 28, 2023 | 78,834.00 |
| Nov 30, 2022 | 76,401.00 |
| Aug 31, 2022 | 80,272.00 |
| May 31, 2022 | 80,896.00 |
| Feb 28, 2022 | 147,220.00 |
| Nov 30, 2021 | 30,439.00 |
| Aug 31, 2021 | 10,004.00 |